Search Results

There are 3480 results for: content related to: CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use

  1. You have free access to this content
    Difference in mesothelin-binding ability of serum CA125 between patients with endometriosis and epithelial ovarian cancer

    International Journal of Cancer

    Volume 136, Issue 8, 15 April 2015, Pages: 1985–1990, Aya Sasaki, Kaoru Akita, Fumitake Ito, Taisuke Mori, Jo Kitawaki and Hiroshi Nakada

    Version of Record online : 17 SEP 2014, DOI: 10.1002/ijc.29185

  2. The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma

    International Journal of Gynecological Cancer

    Volume 12, Issue 5, September 2002, Pages: 438–442, U. Saygili, S. Guclu, T. Uslu, O. Erten and E. Dogan

    Version of Record online : 15 OCT 2002, DOI: 10.1046/j.1525-1438.2002.01171.x

  3. You have free access to this content
    Serum Carbohydrate Antigen 125 Levels in Nonischemic Dilated Cardiomyopathy: A Useful Biomarker for Prognosis and Functional Mitral Regurgitation

    Congestive Heart Failure

    Volume 18, Issue 3, May/June 2012, Pages: 144–150, Oguz Karaca, Gamze B. Guler, Ekrem Guler, H. Murat Gunes, Elnur Alizade, Hicaz Z. Agus, Gokhan Gol, Gokhan Kahveci, Ozlem Esen, A. Metin Esen and Muhsin Turkmen

    Version of Record online : 12 NOV 2011, DOI: 10.1111/j.1751-7133.2011.00260.x

  4. Preoperative CA125 as a prognostic factor in stage I epithelial ovarian cancer

    APMIS

    Volume 114, Issue 5, May 2006, Pages: 359–363, ANETTE LYKKE PETRI, ESTRID HØGDALL, IB JARLE CHRISTENSEN, SUSANNE KRÜGER KJAER, JAN BLAAKÆR and CLAUS KIM HØGDALL

    Version of Record online : 24 MAY 2006, DOI: 10.1111/j.1600-0463.2006.apm_397.x

  5. Diagnostic and prognostic value of serum human epididymis protein 4 in patients with primary fallopian tube carcinoma

    Journal of Obstetrics and Gynaecology Research

    Volume 42, Issue 10, October 2016, Pages: 1326–1335, Dong Mi, Yue-Xiang Zhang, Cheng-Jin Wang, Qiang Feng, Pei Qi and Shu-Qin Chen

    Version of Record online : 16 JUN 2016, DOI: 10.1111/jog.13053

  6. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer

    Australian and New Zealand Journal of Obstetrics and Gynaecology

    Volume 51, Issue 5, October 2011, Pages: 397–402, Yu-Li CHEN, Chia-Yen HUANG, Tsai-Yen CHIEN, Shih-Hung HUANG, Ching-Jung WU and Chih-Ming HO

    Version of Record online : 9 JUN 2011, DOI: 10.1111/j.1479-828X.2011.01325.x

  7. You have free access to this content
    Carbohydrate Antigen 125 Predicts Long-Term Mortality in African American Patients With Acute Decompensated Heart Failure

    Congestive Heart Failure

    Volume 16, Issue 1, January/February 2010, Pages: 15–20, Ibrahim N. Mansour, Sirikarn Napan, M. Tarek Alahdab and Thomas D. Stamos

    Version of Record online : 10 AUG 2009, DOI: 10.1111/j.1751-7133.2009.00110.x

  8. What should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma?

    International Journal of Gynecological Cancer

    Volume 7, Issue 1, January 1997, Pages: 42–45, T. Beşe, F. Demi̇rkiran, M. Arvas, A.U. öz, D. Kösebay and E. Erkün

    Version of Record online : 10 JUN 2003, DOI: 10.1046/j.1525-1438.1997.00422.x

  9. You have free access to this content
    Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment

    Intervention Review

    The Cochrane Library

    Tilean Clarke, Khadra Galaal, Andrew Bryant and Raj Naik

    Published Online : 8 SEP 2014, DOI: 10.1002/14651858.CD006119.pub3

  10. Serum CA125 level before the development of ovarian cancer

    International Journal of Gynecology & Obstetrics

    Volume 99, Issue 2, November 2007, Pages: 95–99, H. Kobayashi, H. Ooi, Y. Yamada, M. Sakata, R. Kawaguchi, S. Kanayama, K. Sumimoto and T. Terao

    Version of Record online : 23 JUL 2007, DOI: 10.1016/j.ijgo.2007.06.003

  11. You have free access to this content
    The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters

    European Journal of Heart Failure

    Volume 7, Issue 2, March 2005, Pages: 199–203, Nikos T. Kouris, Ioannis D. Zacharos, Dimitra D. Kontogianni, Georgia S. Goranitou, Maria D. Sifaki, Haris E. Grassos, Eleni M. Kalkandi and Dimitris K. Babalis

    Version of Record online : 8 FEB 2005, DOI: 10.1016/j.ejheart.2004.07.015

  12. Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 18, Issue 4, July/August 2008, Pages: 621–628, A.H.M.M. ARITS, J.E.G.M. STOOT, A.A.M. BOTTERWECK, F.J.M.E. ROUMEN and A.C. VOOGD

    Version of Record online : 14 SEP 2007, DOI: 10.1111/j.1525-1438.2007.01064.x

  13. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma

    European Journal of Haematology

    Volume 78, Issue 5, May 2007, Pages: 399–404, Christophe Bonnet, Yves Beguin, Marie-France Fassotte, Laurence Seidel, Françoise Luyckx and Georges Fillet

    Version of Record online : 28 FEB 2007, DOI: 10.1111/j.1600-0609.2007.00843.x

  14. A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancer

    International Journal of Gynecological Cancer

    Volume 15, Issue 6, November 2005, Pages: 1023–1034, T.G. EHLEN, P.J. HOSKINS, D. MILLER, T.L. WHITESIDE, C.F. NICODEMUS, B.C. SCHULTES and K.D. SWENERTON

    Version of Record online : 17 NOV 2005, DOI: 10.1111/j.1525-1438.2005.00483.x

  15. You have free access to this content
    A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value

    Cancer

    Volume 119, Issue 19, 1 October 2013, Pages: 3454–3461, Karen H. Lu, Steven Skates, Mary A. Hernandez, Deepak Bedi, Therese Bevers, Leroy Leeds, Richard Moore, Cornelius Granai, Steven Harris, William Newland, Olasunkanmi Adeyinka, Jeremy Geffen, Michael T. Deavers, Charlotte C. Sun, Nora Horick, Herbert Fritsche and Robert C. Bast Jr

    Version of Record online : 26 AUG 2013, DOI: 10.1002/cncr.28183

  16. You have free access to this content
    Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor α levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma

    Cancer

    Volume 95, Issue 9, 1 November 2002, Pages: 1886–1893, Paweł Sedlaczek, Irena Frydecka, Marian Gabryś, Arie van Dalen, Roland Einarsson and Antonina Harłozińska

    Version of Record online : 25 OCT 2002, DOI: 10.1002/cncr.10917

  17. Stage- and CA125–related survival in patients with epithelial ovarian cancer treated at a cancer center

    International Journal of Gynecological Cancer

    Volume 16, Issue S1, February 2006, Pages: 18–24, R.E. BOARD, C.T.P.H. BRUIJNS, A.E. PRONK, W.D.J. RYDER, P.M. WILKINSON, R. WELCH, J.H. SHANKS, G. CONNOLLY, R.J. SLADE, K. REYNOLDS, H.C. KITCHENER and G.C. JAYSON

    Version of Record online : 24 FEB 2006, DOI: 10.1111/j.1525-1438.2006.00308.x

  18. Tissue and serum CA125 expression in endometrial cancer

    International Journal of Gynecological Cancer

    Volume 12, Issue 4, July 2002, Pages: 372–375, S. Ginath, J. Menczer, Y. Fintsi, E. Ben-Shem, M. Glezerman and I. Avinoach

    Version of Record online : 1 AUG 2002, DOI: 10.1046/j.1525-1438.2002.01007.x

  19. Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer

    Journal of Obstetrics and Gynaecology Research

    Volume 32, Issue 3, June 2006, Pages: 309–314, Mitsuhiro Nakae, Ichiro Iwamoto, Toshinori Fujino, Yoshiyasu Maehata, Shin-ichi Togami, Mitsuhiro Yoshinaga and Tsutomu Douchi

    Version of Record online : 5 JUN 2006, DOI: 10.1111/j.1447-0756.2006.00403.x

  20. Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue S1, February 2006, Pages: 99–107, M. MURAKAMI, T. MIYAMOTO, T. IIDA, H. TSUKADA, M. WATANABE, M. SHIDA, H. MAEDA, S. NASU, S. YASUDA, M. YASUDA and M. IDE

    Version of Record online : 24 FEB 2006, DOI: 10.1111/j.1525-1438.2006.00471.x